Final Analysis Of The Phase Ii Randomized Discontinuation Trial (Rdt) Of Tivozanib (Av-951) Versus Placebo In Patients With Renal Cell Carcinoma (Rcc)
JOURNAL OF CLINICAL ONCOLOGY(2011)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
JOURNAL OF CLINICAL ONCOLOGY(2011)